Stats by Source
Total, split by cell line (COSMIC CL / DepMap / PubMed) vs tissue (COSMIC primary tissue)
Total = all mutations for this gene across every source.
Cell line = COSMIC Cell Lines Project + DepMap + PubMed.
Tissue = COSMIC primary-tissue (patient tumour) samples.
Total can exceed cell line + tissue: COSMIC tissue-derived models sit only in global, and a peptide can be shared across both.
| Total | Cell line | Tissue | |
|---|---|---|---|
| Mutations | 327 | 55 | 268 |
| Samples | 143 | 35 | 105 |
| Peptides | 105 | 19 | 88 |
Function
DAOA · D-amino acid oxidase activator
This gene encodes a protein that may function as an activator of D-amino acid oxidase, which degrades the gliotransmitter D-serine, a potent activator of N-methyl-D-aspartate (NMDA) type glutamate receptors. Studies also suggest that one encoded isoform may play a role in mitochondrial function and dendritic arborization. Polymorphisms in this gene have been implicated in susceptibility to schizophrenia and bipolar affective disorder. Alternatively spliced transcript variants encoding different isoforms have been identified.[provided by RefSeq, Mar 2011].
Isoforms & Proteins
4 transcripts · UniProt mapping is sequence-verified (AA-safe)
Each Ensembl transcript (ENST) this gene is mutated on, with its matched UniProt accession.
The mapping is sequence-verified: the UniProt sequence is identical to the transcript translation, so amino-acid positions line up exactly. A * marks an unreviewed (TrEMBL) entry.
Counts are mutations and unique mutant peptides on each transcript.
Gene Properties
Recurrent Mutations
All 100 amino-acid changes on canonical ENST00000375936 · needle height = samples · drag the mini-map to zoom
A lollipop / needle plot – the standard way to show recurrent mutations along a protein (as used by cBioPortal and MutationMapper).
X-axis = amino-acid position in the protein.
Needle height & head size = how often that exact amino-acid change was observed (its recurrence). Tall/large heads are mutational hotspots.
The most recurrent changes are labelled; hover any needle for the change, position and counts.
Mutation frequency across cancer types
% of samples with a missense/complex mutation in DAOA · cell line vs tissue
For each cancer type, the fraction of samples that carry at least one missense/complex mutation anywhere in DAOA – counted as distinct samples (a sample counts once no matter how many mutations it has).
Split into cell line and tissue; each cell shows mutated / total and the percentage. Cohorts with <20 samples are omitted. Ordered by combined frequency.
| Cancer type | Cell lines | Tissue samples |
|---|---|---|
| Melanoma | 7/210 3% | 25/1899 1% |
| Endometrial Carcinoma | 1/42 2% | 8/612 1% |
| Burkitts Lymphoma | 2/32 6% | 0/196 0% |
| Non-Small Cell Lung Carcinoma | 6/304 2% | 8/1390 1% |
| Gastrointestinal Stromal Tumour | 0/0 0% | 1/133 1% |
| Neuroendocrine Tumour | 2/154 1% | 2/577 0% |
| Germ Cell Tumour | 0/25 0% | 1/169 1% |
| Bladder Carcinoma | 0/58 0% | 5/956 1% |
| Colorectal Carcinoma | 4/143 3% | 12/3239 0% |
| Cervical Carcinoma | 0/35 0% | 2/422 0% |
| Mesothelioma | 1/62 2% | 0/165 0% |
| Gastric Carcinoma | 1/74 1% | 7/1809 0% |
| Small Cell Lung Carcinoma | 0/9 0% | 3/752 0% |
| Esophageal Carcinoma | 0/23 0% | 3/769 0% |
| Squamous Cell Lung Carcinoma | 0/57 0% | 3/810 0% |
| Hepatocellular Carcinoma | 0/46 0% | 7/2210 0% |
| Other Solid Cancers | 0/94 0% | 5/1515 0% |
| Plasma Cell Myeloma | 0/44 0% | 1/305 0% |
| Glioma | 2/52 4% | 4/2127 0% |
| Esophageal Squamous Cell Carcinoma | 2/51 4% | 5/2550 0% |
| Biliary Tract Carcinoma | 0/54 0% | 2/950 0% |
| Other Sarcomas | 0/69 0% | 1/699 0% |
| Breast Carcinoma | 3/144 2% | 1/3264 0% |
| Non-Cancerous | 0/104 0% | 1/830 0% |
| B-Cell Non-Hodgkins Lymphoma | 2/88 2% | 1/2534 0% |
| Thyroid Gland Carcinoma | 1/45 2% | 0/1592 0% |
| Other Blood Cancers | 1/61 2% | 0/2725 0% |
Mutation Distribution
Where DAOA is mutated · all tissues, split by cell line vs tissue
How many mutations in DAOA were found in each tissue, across the whole database.
Each bar is a tissue (cell-line and tissue names are merged to the standard tissue), split into cell line and tissue (patient tumour) contributions.
This shows the cancer-context where this gene is recurrently altered.
Mutations
All 327 mutations in DAOA
Every mutation record for this gene, across all samples and sources.
The Sample column links to the cell line (cell-line samples) or the tissue type (tissue samples).
Use the Type / Source filters, the search box, and column sorting to explore; each CAN-IMMUNE ID opens the full mutation & peptide view.
| ID | Sample | Transcript | AA Change | CDS | Type | Source | Mutant Peptide | Wild-type Peptide |
|---|